European Medicines Agency Confirms blood clot link with AstraZeneca Covid vaccine

Eloise Marshall
April 6, 2021

What causes this reaction, however, we still do not know.

"In the next few hours, we will say that there is a connection, but we still have to understand how this happens".

A total of 5.4 million people have received a second dose.

Data up to April 5 shows that of the 37,119,083 jabs given in the United Kingdom so far, 31,622,367 were first doses - a rise of 40,744 on the previous day.

However, Marco Cavaleri, head of vaccine strategy at the EMA, told an Italian newspaper that full evaluation work was still "far from being completed" and that the risk-benefit ratio was still in favour of the vaccine.

AstraZeneca's vaccine, developed with the University of Oxford, is under mounting scrutiny and has faced dwindling support in Europe.

"Now we can say it, it is clear that there is a link with the vaccine".

After several countries suspended the use of the jab - including Italy - the EMA declared that the benefits outweigh the risks and it should remain in use.

Derek Chauvin trial: Kneeling on Floyd's neck violated policy, says police chief
Langenfeld also testified that neither he nor paramedics administered a drug that would reverse the effects of an opioid overdose. She testified that she called her supervisor because she was concerned while watching camera surveillance of Floyd's arrest.


But it has said there is a possible link to rare blood clots and that it would issue updated advice during this week's meeting of its safety committee.

These cases were spread across 2.8 million AstraZeneca vaccine doses injected, or just over one case per 100,000 doses.

Mr Zahawi re-confirmed the Government's target after reports that the Medicines and Healthcare products Regulatory Agency (MHRA) is considering proposals to restrict the use of the AstraZeneca jab in younger people.

Some countries, including France, Germany and the Netherlands, have suspending the use of the vaccine in younger people while the investigations continue.

The majority of Australia's near 26 million population will be administered the AstraZeneca vaccine, with 50 million doses set to be produced locally from the end of March.

But, he said, there were some "clear certainties around" including the facts that both of the vaccines used in the United Kingdom were "highly effective against Covid" while the risk of getting sick or dying with Covid for those who are now being offered doses, "are far and away greater than any small theoretical risk that may exist relating to these cases".

"Our thorough and detailed review is ongoing into reports of very rare and specific types of blood clots with low platelets following the Covid-19 vaccine AstraZeneca".

Other reports by

Discuss This Article

FOLLOW OUR NEWSPAPER